BTC Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $542K | Buy |
8,303
+47
| +0.6% | +$3.07K | 0.04% | 158 |
|
|
2025
Q1 | $553K | Sell |
8,256
-2,367
| -22% | -$158K | 0.05% | 152 |
|
|
2024
Q4 | $587K | Buy |
10,623
+1,172
| +12% | +$64.8K | 0.05% | 152 |
|
|
2024
Q3 | $564K | Buy |
9,451
+1,341
| +17% | +$80K | 0.05% | 161 |
|
|
2024
Q2 | $516K | Sell |
8,110
-279
| -3% | -$17.8K | 0.05% | 158 |
|
|
2024
Q1 | $580K | Buy |
+8,389
| New | +$580K | 0.05% | 159 |
|
|
2023
Q3 | $365K | Sell |
6,294
-1,043
| -14% | -$60.6K | 0.04% | 181 |
|
|
2023
Q2 | $397K | Buy |
7,337
+693
| +10% | +$37.5K | 0.04% | 185 |
|
|
2023
Q1 | $263K | Sell |
6,644
-1,573
| -19% | -$62.2K | 0.03% | 203 |
|
|
2022
Q4 | $331K | Buy |
+8,217
| New | +$331K | 0.04% | 196 |
|
|
2022
Q1 | – | Sell |
-7,462
| Closed | -$343K | – | 260 |
|
|
2021
Q4 | $343K | Buy |
+7,462
| New | +$343K | 0.03% | 227 |
|